Aimmune Therapeutics, Inc.

/Aimmune Therapeutics, Inc.

They are a clinical-stage biopharmaceutical company developing treatments for potentially life-threatening food allergies.

Symbol

Last Closing Price
$32.21

Shares
4,300,000

Effective Date
February 22, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange